Man Group plc - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
Man Group plc ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$5,960,860
+1868.8%
132,493
+1817.1%
0.02%
+2000.0%
Q4 2022$302,771
-89.2%
6,911
-83.8%
0.00%
-92.3%
Q3 2022$2,803,000
-38.9%
42,540
-0.6%
0.01%
-13.3%
Q4 2021$4,584,000
-25.7%
42,797
-28.7%
0.02%
-31.8%
Q3 2021$6,172,000
+15.8%
60,035
-0.9%
0.02%
+15.8%
Q2 2021$5,330,000
+271.7%
60,593
+310.9%
0.02%
+216.7%
Q1 2021$1,434,000
-81.4%
14,746
-78.6%
0.01%
-82.4%
Q4 2020$7,717,000
-7.5%
68,813
-23.5%
0.03%
+3.0%
Q3 2020$8,343,000
-4.7%
89,999
-19.8%
0.03%
-25.0%
Q2 2020$8,754,000
+91.1%
112,232
+43.2%
0.04%
+46.7%
Q1 2020$4,582,000
+108.5%
78,352
+185.6%
0.03%
+328.6%
Q4 2019$2,198,000
-32.3%
27,437
-37.9%
0.01%
-41.7%
Q3 2019$3,247,000
-35.0%
44,195
-16.6%
0.01%
-33.3%
Q2 2019$4,999,000
+475.9%
52,996
+388.5%
0.02%
+500.0%
Q1 2019$868,000
+146.6%
10,849
+66.0%
0.00%
+50.0%
Q4 2018$352,000
-76.2%
6,535
-65.4%
0.00%
-60.0%
Q3 2018$1,476,000
-60.3%
18,905
-67.7%
0.01%
-66.7%
Q2 2018$3,718,00058,5810.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders